Schultz, Jussi http://orcid.org/0000-0001-7372-688X
van den Hoogen, Inge J.
Kuneman, Jurrien H.
de Graaf, Michiel A.
Kamperidis, Vasileios
Broersen, Alexander
Jukema, J. Wouter
Sakellarios, Antonis
Nikopoulos, Sotirios
Tsarapatsani, Konstantina
Naka, Katerina
Michalis, Lampros
Fotiadis, Dimitrios I.
Maaniitty, Teemu
Saraste, Antti
Bax, Jeroen J.
Knuuti, Juhani
Funding for this research was provided by:
Sydäntutkimussäätiö
Academy of Finland
Turun Yliopistollinen Keskussairaala
University of Turku (UTU) including Turku University Central Hospital
Article History
Received: 12 May 2022
Accepted: 27 September 2022
First Online: 18 October 2022
Declarations
:
: Schultz received grants from the Finnish Foundation for Cardiovascular Research. Saraste received grants from the Academy of Finland and Finnish Foundation for Cardiovascular Research, consultancy fees from Amgen, Astra Zeneca, Boehringer Ingelheim, and Pfizer and speaker fees from Abbott and Bayer. Bax received speaker fees from Abbot Vascular and Edwards Lifesciences. Knuuti received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer and Merck, outside of the submitted work. The Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands has received unrestricted research grants from Bayer, Abbott Vascular, Medtronic, Biotronik, Boston Scientific, GE Healthcare and Edwards Lifesciences. Jukema/his department has received research grants from and/or was speaker (with or without lecture fees) on a.o. (CME accredited) meetings sponsored by Amarin, Amgen, Athera,, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, The Medicine Company, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme. The remaining authors have no relevant disclosures.
: The study protocol was approved by the ethics committee of the Hospital District of South-West Finland, and the need for written informed consent was waived. The study was conducted in direct compliance with the Declaration of Helsinki.